Healthcare >> CEO Interviews >> November 24, 2003
RAPHAEL J. MANNINO is Executive Vice President, Chief Scientific Officer
and a Founder of BioDelivery Sciences International, Inc. and has served
as a member of the Board of Directors since the incorporation of BDS in
1995. Dr. Mannino is a world leader in cochleate technology and an
internationally recognized expert in applying artificial lipid-based
delivery systems to problems in biotechnology, including drug delivery,
vaccine design and gene therapy applications. Dr. Mannino's
contributions to this field have resulted in numerous peer reviewed
publications, book chapters, presentations at national and international
symposia, and 11 US patents. Dr. Mannino received his doctoral training
in Biological Chemistry from the Johns Hopkins University, School of
Medicine, and held faculty positions at UMDNJ, New Jersey Medical School
and The Albany Medical College. Profile
an overview of BioDelivery Sciences International's products?
Dr. Mannino: Fundamentally, BioDelivery Sciences is working
